Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Castlight Health Announces Fourth Quarter and Full Year 2017 Results

      Full Year 2017 Total Revenue of $131.4 million, Up 29% Year-over-Year

      Castlight Logo (PRNewsfoto/Castlight Health)

      News provided by

      Castlight Health, Inc.

      Feb 21, 2018, 04:20 ET

      Share this article

      Share this article


      SAN FRANCISCO, Feb. 21, 2018 /PRNewswire/ -- Castlight Health, Inc. (NYSE: CSLT), a leading health benefits platform provider, today announced results for its fourth quarter and full year ended December 31, 2017.

      "2017 was a transformative year for Castlight. We expanded our capabilities into wellbeing, re-accelerated growth of annualized recurring revenues compared to 2016, and positioned the business to reach breakeven in the fourth quarter of this year," said John Doyle, chief executive officer of Castlight Health. "As we look ahead, we believe Castlight is in a great position to address the critical needs of employers and employees as individuals play an increasingly central role in the health care system."

      Financial performance for the three months ended December 31, 2017 compared to the three months ended December 31, 2016 includes:

      • GAAP total revenue of $37.0 million, representing an increase of 24%
      • GAAP gross margin of 63.7%, compared to 71.9%
      • Non-GAAP gross margin of 67.7% compared to 74.8%
      • GAAP operating loss of $8.9 million, compared to a loss of $9.2 million
      • Non-GAAP operating loss of $5.8 million, compared to a loss of $1.5 million
      • GAAP net loss per basic and diluted share of $0.06, compared to a net loss per basic and diluted share of $0.09
      • Non-GAAP net loss per basic and diluted share of $0.04, compared to a net loss per basic and diluted share of $0.01
      • Cash used in operations of $0.1 million, compared to $1.7 million used in operations

      Financial performance for the twelve months ended December 31, 2017 compared to the twelve months ended December 31, 2016 includes:

      • GAAP total revenue of $131.4 million, representing an increase of 29%
      • GAAP gross margin of 64.1%, compared to 66.0%
      • Non-GAAP gross margin of 68.6% compared to 69.5%
      • GAAP operating loss of $61.4 million, compared to a loss of $59.0 million
      • Non-GAAP operating loss of $27.7 million, compared to a loss of $30.6 million
      • GAAP net loss per basic and diluted share of $0.44, compared to a net loss per basic and diluted share of $0.58
      • Non-GAAP net loss per basic and diluted share of $0.22, compared to a net loss per basic and diluted share of $0.30
      • Cash used in operations of $23.5 million, compared to $37.0 million used in operations

      Total cash, cash equivalents and marketable securities was $93.3 million as of December 31, 2017.

      The financial performance of Jiff, Inc., which Castlight acquired on April 3, 2017, is not included in the metrics for fiscal year and fourth quarter ended December 31, 2016. A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."

      Castlight adopted the new accounting standard ASC 606, effective January 1, 2018, and will use the full retrospective method of adoption. As such, Castlight will restate its historical financial information for fiscal years 2016 and 2017, as well as quarterly 2017. The Company expects to provide these restatements next quarter. Based on our preliminary review of ASC 606's impact, the Company currently expects to see a reduction of 2018 revenue by approximately $2 million compared to what it would have expected under the former ASC 605 standard.

      Business Outlook

      The Company's outlook is based on the new revenue recognition standard ASC 606. For the full year 2018, the Company expects:

      • GAAP revenue in the range of $150 million to $155 million
      • Non-GAAP operating loss in the range of $15 million to $20 million
      • Non-GAAP net loss per share of approximately $0.11 to $0.15 based on approximately 137 million to 138 million shares

      Quarterly Conference Call

      Castlight Health senior management will host a conference call to discuss its fourth quarter 2017 results and business outlook today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations website at http://ir.castlighthealth.com. An archive of the webcast can also be accessed through the same link. The live conference call can be accessed by dialing (866) 393-4306 and the replay will be available for one week at (855) 859-2056.  The conference ID number for the live call and replay is 5381456.

      About Castlight Health

      Castlight is on a mission to make it as easy as humanly possible to navigate healthcare and live happier, healthier, more productive lives. Our health navigation platform connects with hundreds of health vendors, benefits resources, and plan designs, giving rise to the world's first comprehensive app for all health needs. We guide individuals - based on their unique profile - to the best resources available to them, whether they are healthy, chronically ill, or actively seeking medical care. In doing so, we help companies regain control over rising healthcare costs and get more value from their benefits investments. Castlight revolutionized the healthcare sector with the introduction of data-driven price transparency tools in 2008 and the first consumer-grade wellbeing platform in 2012. Today, Castlight serves as the health navigation platform for millions of people and is a trusted partner to many of the largest employers in the world.

      For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook.

      Non-GAAP Financial Measures

      To supplement Castlight Health's financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross profit and margin, non-GAAP operating expense, non-GAAP operating loss, non-GAAP other income, net, non-GAAP net loss and non-GAAP net loss per share. Non-GAAP gross profit and margin, non-GAAP operating expense, non-GAAP operating loss, non-GAAP other income, net and non-GAAP net loss exclude stock-based compensation, litigation settlement, charges related to a reduction in workforce, amortization of intangibles, capitalization and amortization of internal-use software, gain on the sale of investment in related party, expense related to expiration of SAP warrant, changes in fair value of contingent consideration and charges related to the acquisition and the associated tax impact of these items, where applicable.

      We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company's core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company's historical financial performance.

      We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the full year 2018 to comparable GAAP operating loss and net loss per share guidance because we do not provide guidance for stock-based compensation expense and capitalization and amortization of internal-use software, which are reconciling items between GAAP and non-GAAP operating loss. The factors that may impact our future stock-based compensation expense and capitalization and amortization of internal-use software are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort. Factors include our market capitalization and related volatility of our stock price and our inability to project the cost or scope of internally produced software.

      These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP.

      Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company's financial information in its entirety and not rely on a single financial measure.

      Safe Harbor For Forward-Looking Statements

      This press release contains forward-looking statements about Castlight Health's expectations, plans, intentions, and strategies, including, but not limited to, statements regarding Castlight Health's 2018 full year projections, our expectations for our future business and financial performance. Statements including words such as "anticipate," "believe," "estimate," "will," "continue," "expect," or "future," and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in Castlight Health's documents filed with or furnished to the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Castlight Health as of the date hereof. Castlight Health assumes no obligation to update these forward-looking statements.

      Copyright 2018 Castlight Health, Inc. Castlight Health® is the registered trademark of Castlight Health, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED BALANCE SHEETS

      (In thousands)



      As of


      December 31,
      2017


      December 31,
      2016


       (unaudited)



      Assets




      Current assets:




      Cash and cash equivalents

      $

      61,319



      $

      48,722


      Marketable securities

      32,025



      65,882


      Accounts receivable, net

      20,761



      14,806


      Deferred commissions

      6,403



      8,218


      Prepaid expenses and other current assets

      3,991



      3,382


      Total current assets

      124,499



      141,010


      Property and equipment, net

      5,263



      5,285


      Restricted cash, non-current

      1,325



      1,144


      Goodwill

      91,785



      —


      Intangible assets, net

      20,253



      —


      Deferred commissions, non-current

      4,180



      5,050


      Other assets

      1,997



      4,677


      Total assets

      $

      249,302



      $

      157,166


      Liabilities and stockholders' equity




      Current liabilities:




      Accounts payable

      $

      3,907



      $

      2,288


      Accrued expenses and other current liabilities

      13,178



      6,369


      Accrued compensation

      13,941



      9,443


      Deferred revenue

      29,410



      30,623


      Total current liabilities

      60,436



      48,723


      Deferred revenue, non-current

      6,686



      5,245


      Debt, non-current

      4,958



      —


      Other liabilities, non-current

      1,900



      1,236


      Total liabilities

      73,980



      55,204


      Commitments and contingencies




      Stockholders' equity:




      Class A and Class B common stock

      13



      10


      Additional paid-in capital

      586,900



      457,596


      Accumulated other comprehensive loss

      (22)



      —


      Accumulated deficit

      (411,569)



      (355,644)


      Total stockholders' equity

      175,322



      101,962


      Total liabilities and stockholders' equity

      $

      249,302



      $

      157,166


      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands, except per share data)

      (unaudited)



      Three Months Ended December 31,


      Year Ended December 31,


      2017


      2016


      2017


      2016

      Revenue:








      Subscription

      $

      33,533



      $

      28,157



      $

      120,496



      $

      95,016


      Professional services and other

      3,480



      1,740



      10,933



      6,684


      Total revenue, net

      37,013



      29,897



      131,429



      101,700


      Cost of revenue:








      Cost of subscription (1)

      8,335



      4,245



      28,410



      16,463


      Cost of professional services and other (1)

      5,095



      4,157



      18,774



      18,098


      Total cost of revenue

      13,430



      8,402



      47,184



      34,561


      Gross profit

      23,583



      21,495



      84,245



      67,139


      Operating expenses:








      Sales and marketing (1)

      15,289



      13,923



      62,313



      58,800


      Research and development (1)

      14,428



      9,841



      54,502



      40,460


      General and administrative (1)

      2,754



      6,957



      28,825



      26,859


      Total operating expenses

      32,471



      30,721



      145,640



      126,119


      Operating loss

      (8,888)



      (9,226)



      (61,395)



      (58,980)


      Other income, net

      330



      128



      618



      432


      Loss before income tax benefit

      (8,558)



      (9,098)



      (60,777)



      (58,548)


      Income tax benefit

      —



      —



      5,206



      —


      Net loss

      $

      (8,558)



      $

      (9,098)



      $

      (55,571)



      $

      (58,548)


      Net loss per share, basic and diluted

      $

      (0.06)



      $

      (0.09)



      $

      (0.44)



      $

      (0.58)


      Weighted-average shares used to compute basic and diluted net loss per share

      134,018



      103,976



      125,534



      100,798



      (1)       Includes stock-based compensation expense as follows:



      Three Months Ended December 31,


      Year Ended December 31,


      2017


      2016


      2017


      2016

      Cost of revenue:








      Cost of subscription

      $

      250



      $

      139



      $

      888



      $

      506


      Cost of professional services and other

      256



      493



      1,656



      1,961


      Sales and marketing

      1,960



      2,199



      9,665



      8,843


      Research and development

      1,740



      1,659



      7,415



      5,959


      General and administrative

      1,368



      1,267



      4,954



      4,743


      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands)

      (unaudited)



      Three Months Ended December 31,


      Year Ended December 31,


      2017


      2016 Adjusted *


      2017


      2016 Adjusted *

      Operating activities:








      Net loss

      $

      (8,558)



      $

      (9,098)



      $

      (55,571)



      $

      (58,548)


      Adjustments to reconcile net loss to net cash used in operating activities:








      Depreciation and amortization

      2,041



      762



      6,613



      3,168


      Stock-based compensation

      5,574



      5,757



      24,578



      22,012


      Amortization of deferred commissions

      4,331



      1,913



      12,453



      5,070


      Release of deferred tax valuation allowance due to business combination

      —



      —



      (5,206)



      —


      Change in fair value of contingent consideration liability

      (3,959)



      —



      (671)



      —


      Accretion and amortization of marketable securities

      (103)



      75



      (83)



      481


      Expense related to expiration of SAP warrant

      1,132



      —



      1,132



      —


      Gain on sale of investment in related party

      (1,375)



      —



      (1,375)



      —


      Changes in operating assets and liabilities:








      Accounts receivable

      5,256



      1,082



      (2,522)



      (2,055)


      Deferred commissions

      (3,090)



      (3,574)



      (9,768)



      (7,977)


      Prepaid expenses and other assets

      2,038



      515



      1,645



      448


      Accounts payable

      363



      (1,335)



      764



      (1,035)


      Accrued expenses and other liabilities

      3,560



      3,755



      6,183



      (291)


      Deferred revenue

      (7,290)



      (1,562)



      (1,629)



      1,756


      Net cash used in operating activities

      (80)



      (1,710)



      (23,457)



      (36,971)


      Investing activities:








      Proceeds from sale of investment in related party

      5,500



      —



      5,500



      —


      Purchase of property and equipment

      (268)



      (115)



      (2,544)



      (1,702)


      Purchase of marketable securities

      (5,806)



      (25,021)



      (62,658)



      (98,184)


      Maturities of marketable securities

      15,943



      20,351



      96,576



      146,508


      Business combination, net of cash acquired

      —



      —



      (2,264)



      —


      Net cash provided by (used in) investing activities

      15,369



      (4,785)



      34,610



      46,622


      Financing activities:








      Proceeds from the exercise of stock options

      1,044



      253



      2,356



      2,829


      Proceeds from issuance of common stock and warrants

      —



      —



      —



      17,358


      Payments of deferred financing costs

      —



      —



      (731)



      (122)


      Net cash provided by financing activities

      1,044



      253



      1,625



      20,065










      Net increase (decrease) in cash, cash equivalents and restricted cash

      16,333



      (6,242)



      12,778



      29,716


      Cash, cash equivalents and restricted cash at beginning of period

      46,311



      56,108



      49,866



      20,150


      Cash, cash equivalents and restricted cash at end of period

      $

      62,644



      $

      49,866



      $

      62,644



      $

      49,866










      * Prior-period information has been restated for the adoption of Accounting Standards Update 2016-18, "Statement of Cash Flows" which was adopted in the fourth quarter of 2017.

      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands)

      (unaudited)



      Three Months Ended December 31,


      Year Ended December 31,


      2017


      2016 Adjusted *


      2017


      2016 Adjusted *

      Non-cash investing and financing activity:








      Non-cash purchase consideration related to acquisition of Jiff

      $

      —



      $

      —



      $

      101,692



      $

      —


      Purchase of property and equipment, accrued but not paid

      (151)



      (20)



      (188)



      (20)










      Reconciliation of cash, cash equivalents and restricted cash:








      Cash and cash equivalents





      $

      61,319



      $

      48,722


      Restricted cash





      1,325



      1,144


      Total cash, cash equivalents and restricted cash





      $

      62,644



      $

      49,866










      * Prior-period information has been restated for the adoption of Accounting Standards Update 2016-18, "Statement of Cash Flows" which was adopted in the fourth quarter of 2017.

      CASTLIGHT HEALTH, INC.

      RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

      (In thousands, except per share data)

      (unaudited)



      Three Months Ended


      Year Ended


      December 31,


      September 30,


      December 31,


      December 31,


      December 31,


      2017


      2017


      2016


      2017


      2016

      Gross profit:










      GAAP gross profit subscription

      $

      25,198



      $

      23,240



      $

      23,912



      $

      92,086



      $

      78,553


      Stock-based compensation

      250



      258



      139



      888



      506


      Amortization of internal-use software

      236



      244



      244



      968



      976


      Amortization of intangibles

      751



      751



      —



      2,253



      —


      Reduction in workforce

      —



      —



      —



      —



      5


      Acquisition related costs

      —



      —



      —



      52



      —


      Non-GAAP gross profit subscription

      $

      26,435



      $

      24,493



      $

      24,295



      $

      96,247



      $

      80,040


      GAAP gross margin subscription

      75.1

      %


      74.1

      %


      84.9

      %


      76.4

      %


      82.7

      %

      Non-GAAP gross margin subscription

      78.8

      %


      78.1

      %


      86.3

      %


      79.9

      %


      84.2

      %











      GAAP gross loss professional services and other

      $

      (1,615)



      $

      (1,689)



      $

      (2,417)



      $

      (7,841)



      $

      (11,414)


      Stock-based compensation

      256



      342



      493



      1,656



      1,961


      Reduction in workforce

      —



      —



      —



      —



      103


      Acquisition related costs

      —



      (4)



      —



      160



      —


      Non-GAAP gross loss professional services

      $

      (1,359)



      $

      (1,351)



      $

      (1,924)



      $

      (6,025)



      $

      (9,350)


      GAAP gross margin professional services and other

      (46.4)%



      (53.0)%



      (139)%



      (71.7)%



      (171)%


      Non-GAAP gross margin professional services and other

      (39.1)%



      (42.0)%



      (111)%



      (55.1)%



      (140)%












      GAAP gross profit

      $

      23,583



      $

      21,551



      $

      21,495



      $

      84,245



      $

      67,139


      Impact of non-GAAP adjustments

      1,493



      1,591



      876



      5,977



      3,551


      Non-GAAP gross profit

      $

      25,076



      $

      23,142



      $

      22,371



      $

      90,222



      $

      70,690


      GAAP gross margin

      63.7

      %


      62.3

      %


      71.9

      %


      64.1

      %


      66.0

      %

      Non-GAAP gross margin

      67.7

      %


      66.9

      %


      74.8

      %


      68.6

      %


      69.5

      %

      Operating expense:










      GAAP sales and marketing

      $

      15,289



      $

      16,006



      $

      13,923



      $

      62,313



      $

      58,800


      Stock-based compensation

      (1,960)



      (3,110)



      (2,199)



      (9,665)



      (8,843)


      Amortization of intangibles

      (448)



      (448)



      —



      (1,344)



      —


      Reduction in workforce

      —



      —



      —



      —



      (422)


      Acquisition related costs

      —



      14



      —



      (909)



      —


      Non-GAAP sales and marketing

      $

      12,881



      $

      12,462



      $

      11,724



      $

      50,395



      $

      49,535


      GAAP research and development

      $

      14,428



      $

      13,809



      $

      9,841



      $

      54,502



      $

      40,460


      Stock-based compensation

      (1,740)



      (1,631)



      (1,659)



      (7,415)



      (5,959)


      Reduction in workforce

      —



      —



      —



      —



      (136)


      Acquisition related costs

      —



      —



      —



      (393)



      —


      Non-GAAP research and development

      $

      12,688



      $

      12,178



      $

      8,182



      $

      46,694



      $

      34,365


      GAAP general and administrative

      $

      2,754



      $

      10,307



      $

      6,957



      $

      28,825



      $

      26,859


      Stock-based compensation

      (1,368)



      (1,121)



      (1,267)



      (4,954)



      (4,743)


      Litigation settlement

      —



      —



      —



      (250)



      (2,876)


      Amortization of intangibles

      (17)



      (17)



      —



      (50)



      —


      Change in fair value of contingent consideration liability

      3,959



      (3,931)



      —



      671



      —


      Reduction in workforce

      —



      —



      —



      —



      (90)


      Acquisition related costs

      (58)



      (126)



      (1,731)



      (3,423)



      (1,731)


      Non-GAAP general and administrative

      $

      5,270



      $

      5,112



      $

      3,959



      $

      20,819



      $

      17,419


      GAAP operating expense

      $

      32,471



      $

      40,122



      $

      30,721



      $

      145,640



      $

      126,119


      Impact of non-GAAP adjustments

      (1,632)



      (10,370)



      (6,856)



      (27,732)



      (24,800)


      Non-GAAP operating expense

      $

      30,839



      $

      29,752



      $

      23,865



      $

      117,908



      $

      101,319


      Operating loss:










      GAAP operating loss

      $

      (8,888)



      $

      (18,571)



      $

      (9,226)



      $

      (61,395)



      $

      (58,980)


      Impact of non-GAAP adjustments

      3,125



      11,961



      7,732



      33,709



      28,351


      Non-GAAP operating loss

      $

      (5,763)



      $

      (6,610)



      $

      (1,494)



      $

      (27,686)



      $

      (30,629)


      Other income, net:










      GAAP other income, net

      $

      330



      $

      84



      $

      128



      $

      618



      $

      432


      Gain on sale of investment in related party

      (1,375)



      —



      —



      (1,375)



      —


      Expense related to expiration of SAP warrant

      1,132



      —



      —



      1,132



      —


      Non-GAAP other income, net

      $

      87



      $

      84



      $

      128



      $

      375



      $

      432


      Net loss and net loss per share:










      GAAP net loss

      $

      (8,558)



      $

      (18,487)



      $

      (9,098)



      $

      (55,571)



      $

      (58,548)


      Total pre-tax impact of non-GAAP adjustments

      2,882



      11,961



      7,732



      33,466



      28,351


      Release of deferred tax valuation allowance due to business combination

      —



      —



      —



      (5,206)



      —


      Non-GAAP net loss

      $

      (5,676)



      $

      (6,526)



      $

      (1,366)



      $

      (27,311)



      $

      (30,197)


      GAAP net loss per share, basic and diluted

      $

      (0.06)



      $

      (0.14)



      $

      (0.09)



      $

      (0.44)



      $

      (0.58)


      Non-GAAP net loss per share, basic and diluted

      $

      (0.04)



      $

      (0.05)



      $

      (0.01)



      $

      (0.22)



      $

      (0.30)


      Shares used in basic and diluted net loss per share computation

      134,018



      132,251



      103,976



      125,534



      100,798


      Castlight Media Contact:
      Shannon Magill
      [email protected] 
      415-829-1500

      Castlight Investor Contact:
      Gary J. Fuges, CFA
      [email protected]
      415-829-1680

      SOURCE Castlight Health, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.